SGBI

Sangui Biotech International, Inc. [SGBI] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SGBI Stock Summary

Top 10 Correlated Stocks

SGBI


In the News

SGBI Financial details

Company Rating
Neutral
Market Cap
733.61K
Income
-165.12K
Revenue
80.86K
Book val./share
-0
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
10 May 2021
P/E
-3.11
Forward P/E
-
PEG
0.93
P/S
8.65
P/B
-1.72
P/C
-
P/FCF
-29.64
Quick Ratio
0.03
Current Ratio
0.04
Debt / Equity
-2.35
LT Debt / Equity
-0.07
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-108.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-2.15%
Revenue Q/Q
75.94%
EPS Q/Q
-50%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-220%
ROE
67%
ROC
0.07%
Gross Margin
100%
Oper. Margin
-95%
Profit Margin
-278%
Payout
-
Shs Outstand
209.9M
Shs Float
182.54M
-
-
-
-
Target Price
-
52W Range
0.002-0.02
52W High
-
52W Low
-
RSI
43.39
Rel Volume
0.03
Avg Volume
3.01K
Volume
100
Perf Week
0%
Perf Month
3.57%
Perf Quarter
-
Perf Half Y
5.45%
-
-
-
-
Beta
0.198
-
-
Volatility
0%, 0%
Prev Close
-16.91%
Price
0.0029
Change
-16.91%

SGBI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-06-30

Metric History 2018-06-302019-06-302020-06-302021-06-30 2022-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
2.82M2.78M2.92M4.51M2.09M
Enterprise value
3.05M3.23M3.59M5.3M2.88M
P/E ratio
-13.99-8.77-13.33-19.12124.21
Price to sales ratio
36.5931.58100.8268.8130.15
POCF ratio
-11.12-8.77-17.31-30.94-14.85
PFCF ratio
-11.12-8.77-17-30.94-14.85
P/B Ratio
10.4156.49-35.17-20.19-8.72
PTB ratio
10.4156.49-35.17-20.19-8.72
EV to sales
39.4936.71124.2880.8541.63
Enterprise value over EBITDA
-15.74-9.57-19.94-35.27-23.57
EV to operating cash flow
-12.01-10.19-21.34-36.36-20.51
EV to free cash flow
-12.01-10.19-20.96-36.36-20.51
Earnings yield
-0.07-0.11-0.08-0.050.01
Free cash flow yield
-0.09-0.11-0.06-0.03-0.07
Debt to equity
0.99.72-8.37-3.67-3.45
Debt to assets
2.396.065.536.116.31
Net debt to EBITDA
-1.15-1.34-3.76-5.25-6.5
Current ratio
0.230.120.060.070.07
Interest coverage
-25.04-28.89-12.87-8.4-7.2
Income quality
1.260.930.850.722.22
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
3.44.536.943.172.88
Research and developement to revenue
0.30.310.290.130.12
Intangibles to total assets
00000
Capex to operating cash flow
000.0200
Capex to revenue
00-0.1100
Capex to depreciation
000.2900
Stock based compensation to revenue
00000
Graham number
0.01000.010
ROIC
-0.38-0.59-0.29-0.260.06
Return on tangible assets
-1.98-4.01-1.75-1.760.13
Graham Net
00000
Working capital
-351.14K-591.99K-742.79K-888.04K-867.91K
Tangible asset value
-351.14K-591.99K-729.88K-875.33K-894.96K
Net current asset value
-351.14K-591.99K-806.51K-942.78K-958.04K
Invested capital
0.99.72-8.37-3.67-3.45
Average receivables
34.22K50.18K31.05K22.47K25.15K
Average payables
189.3K176.94K141.7K123.28K127.85K
Average inventory
00000
Days sales outstanding
275.87174.4253.13138.45134.09
Days payables outstanding
1.12M0000
Days of inventory on hand
00000
Receivables turnover
1.322.091.442.642.72
Payables turnover
00000
Inventory turnover
00000
ROE
-0.74-6.442.641.06-0.07
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q3

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
3.98M2.04M2.41M925.9K965.8K
Enterprise value
4.79M2.84M3.17M1.75M1.79M
P/E ratio
-66.916.739.38-1.3-2.95
Price to sales ratio
221.52194.3958.8587.1351.66
POCF ratio
-160.53-54.69-93.99188.963.85K
PFCF ratio
-160.53-54.69-93.99188.963.85K
P/B Ratio
-16.68-8.54-11.64-2.94-2.73
PTB ratio
-16.68-8.54-11.64-2.94-2.73
EV to sales
266.65270.0377.3164.495.89
Enterprise value over EBITDA
-147.25-211.66-274.78-76.8-99.37
EV to operating cash flow
-193.24-75.97-123.46356.557.14K
EV to free cash flow
-193.24-75.97-123.46356.557.14K
Earnings yield
00.010.03-0.19-0.08
Free cash flow yield
-0.01-0.02-0.010.010
Debt to equity
-3.68-3.45-3.68-2.64-2.35
Debt to assets
4.716.315.998.389.36
Net debt to EBITDA
-24.93-59.29-65.59-36.1-45.84
Current ratio
0.120.070.080.040.04
Interest coverage
-6.24-8.87-3.2-5.4-4.4
Income quality
1.63.81-1.03-0.05-0.01
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
2.465.331.333.412.18
Research and developement to revenue
0.110.20.060.160.04
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0000.010
ROIC
00.23-0.07-0.08-0.09
Return on tangible assets
-0.080.230.5-1.8-0.92
Graham Net
0000-0.01
Working capital
-861.21K-867.91K-838.16K-946.3K-988.12K
Tangible asset value
-891.91K-894.96K-861.5K-970.11K-1.01M
Net current asset value
-963.69K-958.04K-915.84K-1.02M-1.06M
Invested capital
-3.68-3.45-3.68-2.64-2.35
Average receivables
30.43K27.47K42.54K45.23K29.42K
Average payables
129.17K128.47K139.06K152.71K166.01K
Average inventory
000-7.96K-7.96K
Days sales outstanding
148.01217.79130.88260.83135.02
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
0.610.410.690.350.67
Payables turnover
00000
Inventory turnover
00000
ROE
0.06-0.13-0.310.570.23
Capex per share
00000

SGBI Frequently Asked Questions

What is Sangui Biotech International, Inc. stock symbol ?

Sangui Biotech International, Inc. is a DE stock and trading under the symbol SGBI

What is Sangui Biotech International, Inc. stock quote today ?

Sangui Biotech International, Inc. stock price is $0.0029 today.

Is Sangui Biotech International, Inc. stock public?

Yes, Sangui Biotech International, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap